Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Receivables (2018 - 2025)

Selectis Health's Change in Receivables history spans 9 years, with the latest figure at $258727.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 53.86% year-over-year to $258727.0; the TTM value through Sep 2025 reached $1.6 million, up 32.74%, while the annual FY2024 figure was $1.6 million, 136.87% up from the prior year.
  • Change in Receivables for Q3 2025 was $258727.0 at Selectis Health, down from $303280.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.3 million in Q2 2022 and bottomed at -$1.9 million in Q3 2022.
  • The 5-year median for Change in Receivables is $369977.0 (2023), against an average of $336067.6.
  • The largest YoY upside for Change in Receivables was 770.63% in 2022 against a maximum downside of 252.15% in 2022.
  • A 5-year view of Change in Receivables shows it stood at -$62725.0 in 2021, then soared by 770.63% to $420652.0 in 2022, then fell by 11.82% to $370925.0 in 2023, then soared by 91.56% to $710529.0 in 2024, then tumbled by 63.59% to $258727.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Change in Receivables are $258727.0 (Q3 2025), $303280.0 (Q2 2025), and $358124.0 (Q1 2025).